SLT Holdings LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 5,000 shares of the company’s stock, valued at approximately $797,000.
A number of other institutional investors have also recently made changes to their positions in the stock. Covestor Ltd purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the fourth quarter valued at approximately $71,000. HighTower Advisors LLC boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 39.8% during the fourth quarter. HighTower Advisors LLC now owns 3,510 shares of the company’s stock valued at $559,000 after purchasing an additional 1,000 shares during the period. Millennium Capital Advisors LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the fourth quarter valued at approximately $648,000. JPMorgan Chase & Co. purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter valued at approximately $3,208,000. Finally, CIBC Private Wealth Group LLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter valued at approximately $351,000.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
NYSEARCA:LABU opened at $175.19 on Monday. Direxion Daily S&P Biotech Bull 3x Shares has a fifty-two week low of $48.10 and a fifty-two week high of $212.45. The business has a 50 day moving average price of $174.28 and a 200-day moving average price of $165.47.
Direxion Daily S&P Biotech Bull 3x Shares Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
